Skip to main content
. 2023 Jun 29;12(3):445–471. doi: 10.1007/s40119-023-00323-8

Fig. 1.

Fig. 1

Findings from the National Heart Failure Registry of India (2022). ARNI angiotensin receptor–neprilysin inhibitors (ARNI), HTN hypertension, HFrEF heart failure with reduced ejection fraction, DM diabetes mellitus, IHD ischemic heart disease, GDMT guideline-directed medical therapy